# The Role of Alternative RNA Splicing on Endothelial Cell Barrier Dysfunction in Acute Respiratory Distress Syndrome

> **NIH NIH P20** · OCEAN STATE RESEARCH INSTITUTE, INC. · 2021 · $305,475

## Abstract

Acute respiratory distress syndrome (ARDS) is a fatal critical illness with mortality rates greater than twenty 
percent despite numerous clinical trials. It is therefore essential to develop better understanding of the basic 
mechanisms of development of ARDS. ARDS is also unique in that it is a common pathway that occurs after 
many disease processes that result in critical illness (shock from trauma or sepsis, burns, pancreatitis). ARDS 
is characterized by vascular permeability leading to edema and accumulation of immune cells in the lung. The 
increased vascular permeability is due to endothelial cell dysfunction and is the focus of this project. Much 
work has focused on gene and protein expression with little known about changes in RNA splicing. RNA 
splicing is a basic molecular function that occurs in all cells directly after RNA transcription, but before protein 
translation in which introns are removed and exons are joined together. Over 90% of human genes with 
multiple exons have alternative splicing events. With such a high rate of variation from the transcribed gene to 
the produced protein, splicing must be under exquisite control, particularly in times of critical illness. Numerous 
proteins are involved in the control of RNA splicing, including U1-70K. Preliminary data suggest that in the lung 
there is no difference in gene expression, but rather multiple sites of alternative splicing of U1-70K. This is 
similar to previous work showing that ARDS leads to alternative splicing of membrane bound proteins resulting 
in a soluble form. We hypothesize that in ARDS alternative splicing alters the protein isoforms of U1-70K in 
endothelial cells. This change in the isoforms, in turn, results in the microvascular permeability and 
sequestration of edema and immune cells in the lungs during ARDS. Aim 1 will determine the isoforms of U1- 
70K in endothelial cells and whether these isoforms are correlated with lung vascular permeability using a 
mouse model of ARDS caused by cecal ligation and puncture. Aim 2 will determine the effects of the 
physiological conditions (high acid, low oxygen) seen in ARDS on the U1-70K isoforms and endothelial cell 
barrier dysfunction. Aim 3 will assess if U1-70K alternative splicing events present in the pre-clinical model are 
present in samples from humans with critical illness. Better understanding of alternative RNA splicing in ARDS 
will allow manipulation of this mechanism to improve outcomes and improve prediction of resolution of this 
devastating syndrome.

## Key facts

- **NIH application ID:** 10200082
- **Project number:** 5P20GM103652-09
- **Recipient organization:** OCEAN STATE RESEARCH INSTITUTE, INC.
- **Principal Investigator:** Sean Farrell Monaghan
- **Activity code:** P20 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $305,475
- **Award type:** 5
- **Project period:** 2013-09-20 → 2021-11-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10200082

## Citation

> US National Institutes of Health, RePORTER application 10200082, The Role of Alternative RNA Splicing on Endothelial Cell Barrier Dysfunction in Acute Respiratory Distress Syndrome (5P20GM103652-09). Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/grant/nih/10200082. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*